Abdulmunem M. Abulayha
Tripoli, TB, Libya
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Anticancer properties of Artemisia species: mechanisms and experimental evidence.
Journal: Molecular biology reports
Published: November 18, 2025
Evaluation of CD20-Positive B Cells in Libyan Lymphoma Patients Following Rituximab Treatment.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: March 23, 2025
Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.
Journal: The Libyan journal of medicine
Published: February 23, 2024
Rituximab increases the cytotoxicities of vincristine and hydroxyurea through caspase-dependent and caspase-independent cell death, respectively.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 26, 2015
Rituximab: modes of action, remaining dispute and future perspective.
Journal: Future oncology (London, England)
Published: December 20, 2014
Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 22, 2013
Hydroxyurea potentiates the caspase-independent killing of B-cell lines by rituximab and GA101.
Journal: Oncology research
Published: October 22, 2013
Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma.
Journal: Leukemia research
Published: April 07, 2009
Showing 1-9 of 9
Last Updated: 09/26/2026